tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Immutep Reports Increased Loss Amid Rising R&D Costs
Company AnnouncementsImmutep Reports Increased Loss Amid Rising R&D Costs
5h ago
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
PremiumRatings
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
23d ago
IMMP
Immutep receives FDA feedback on clinical development of eftilagimod alfa
PremiumThe Fly
Immutep receives FDA feedback on clinical development of eftilagimod alfa
24d ago
IMMP
Immutep Gains FDA Support for Cancer Therapy Development
PremiumCompany Announcements
Immutep Gains FDA Support for Cancer Therapy Development
24d ago
Immutep reports Q4 cash receipts from customers A$6,000
PremiumThe Fly
Immutep reports Q4 cash receipts from customers A$6,000
30d ago
IMMP
Immutep Advances Oncology Trials with Promising Results
PremiumCompany AnnouncementsImmutep Advances Oncology Trials with Promising Results
1M ago
Immutep’s Eftilagimod Alfa Trials to be Showcased at ESMO 2025
Premium
Company Announcements
Immutep’s Eftilagimod Alfa Trials to be Showcased at ESMO 2025
1M ago
JPMorgan Ceases Substantial Holding in Immutep Ltd
Premium
Company Announcements
JPMorgan Ceases Substantial Holding in Immutep Ltd
1M ago
Immutep Ltd Reports Changes in Substantial Holdings
PremiumCompany Announcements
Immutep Ltd Reports Changes in Substantial Holdings
1M ago
Immutep Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Immutep Ltd Announces Quotation of New Securities on ASX
1M ago
Immutep Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Immutep Ltd Announces Quotation of New Securities on ASX
1M ago
JPMorgan Chase Reduces Stake in Immutep Ltd
PremiumCompany Announcements
JPMorgan Chase Reduces Stake in Immutep Ltd
1M ago
Immutep Ltd Substantial Holder Increases Stake
PremiumCompany AnnouncementsImmutep Ltd Substantial Holder Increases Stake
2M ago
Immutep announces initial efficacy data from Phase I study of IMP761
Premium
The Fly
Immutep announces initial efficacy data from Phase I study of IMP761
2M ago
IMMP
Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
Premium
Company Announcements
Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
3M ago
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
PremiumThe Fly
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
3M ago
IMMP
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
PremiumCompany Announcements
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
3M ago
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
PremiumRatings
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
3M ago
IMMP
Immutep announces response rates from INSIGHT-003 trial
PremiumThe Fly
Immutep announces response rates from INSIGHT-003 trial
4M ago
IMMP
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
PremiumCompany AnnouncementsImmutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
MRK
ATHE
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
4M ago
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >